Protective effects of novel derivatives of vitamin D3 and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms

Redox Biol. 2019 Jun:24:101206. doi: 10.1016/j.redox.2019.101206. Epub 2019 Apr 20.

Abstract

We tested whether novel CYP11A1-derived vitamin D3- and lumisterol-hydroxyderivatives, including 1,25(OH)2D3, 20(OH)D3, 1,20(OH)2D3, 20,23(OH)2D3, 1,20,23(OH)3D3, lumisterol, 20(OH)L3, 22(OH)L3, 20,22(OH)2L3, and 24(OH)L3, can protect against UVB-induced damage in human epidermal keratinocytes. Cells were treated with above compounds for 24 h, then subjected to UVB irradiation at UVB doses of 25, 50, 75, or 200 mJ/cm2, and then examined for oxidant formation, proliferation, DNA damage, and the expression of genes at the mRNA and protein levels. Oxidant formation and proliferation were determined by the DCFA-DA and MTS assays, respectively. DNA damage was assessed using the comet assay. Expression of antioxidative genes was evaluated by real-time RT-PCR analysis. Nuclear expression of CPD, phospho-p53, and Nrf2 as well as its target proteins including HO-1, CAT, and MnSOD, were assayed by immunofluorescence and western blotting. Treatment of cells with the above compounds at concentrations of 1 or 100 nM showed a dose-dependent reduction in oxidant formation. At 100 nM they inhibited the proliferation of cultured keratinocytes. When keratinocytes were irradiated with 50-200 mJ/cm2 of UVB they also protected against DNA damage, and/or induced DNA repair by enhancing the repair of 6-4PP and attenuating CPD levels and the tail moment of comets. Treatment with test compounds increased expression of Nrf2-target genes involved in the antioxidant response including GR, HO-1, CAT, SOD1, and SOD2, with increased protein expression for HO-1, CAT, and MnSOD. The treatment also stimulated the phosphorylation of p53 at Ser-15, increased its concentration in the nucleus and enhanced Nrf2 translocation into the nucleus. In conclusion, pretreatment of keratinocytes with 1,25(OH)2D3 or CYP11A1-derived vitamin D3- or lumisterol hydroxy-derivatives, protected them against UVB-induced damage via activation of the Nrf2-dependent antioxidant response and p53-phosphorylation, as well as by the induction of the DNA repair system. Thus, the new vitamin D3 and lumisterol hydroxy-derivatives represent promising anti-photodamaging agents.

Keywords: Epidermal keratinocytes; Lumisterol (L(3)); Nuclear factor E2-related factor 2 (Nrf2); Photoprotective effects; Ultraviolet B (UVB); Vitamin D(3) hydroxy-derivatives.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antioxidants / metabolism
  • Cells, Cultured
  • Cholecalciferol / analogs & derivatives
  • Cholecalciferol / chemistry
  • Cholecalciferol / pharmacology*
  • DNA Damage
  • Ergosterol / chemistry
  • Ergosterol / pharmacology*
  • Gene Expression Profiling
  • Humans
  • Keratinocytes / drug effects*
  • Keratinocytes / metabolism*
  • Keratinocytes / radiation effects*
  • Molecular Structure
  • NF-E2-Related Factor 2 / metabolism*
  • Oxidation-Reduction / drug effects
  • Oxidative Stress / drug effects
  • Oxidative Stress / radiation effects
  • Protective Agents / chemistry
  • Protective Agents / pharmacology
  • Signal Transduction
  • Tumor Suppressor Protein p53 / metabolism*
  • Ultraviolet Rays / adverse effects*

Substances

  • Antioxidants
  • NF-E2-Related Factor 2
  • Protective Agents
  • Tumor Suppressor Protein p53
  • Cholecalciferol
  • Ergosterol